[Form 4] SCHWAB CHARLES CORP Insider Trading Activity
Paul V. Woolway, MD, Chief Banking Officer of Schwab Charles Corp (SCHW), reported multiple sales of company common stock on 10/01/2025. The Form 4 shows two Rule 10b5-1 plan sales of 1,913 and 1,292 shares (both marked S(1)) and another reported disposal of 25,153 shares. The reporting person states the sales were made under a Rule 10b5-1 trading plan adopted on November 15, 2024. Execution occurred in multiple trades at prices ranging from $92.49 to $94.25, with weighted average prices reported as $93.0449 and $93.7434. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Paul V. Woolway, MD, Chief Banking Officer di Schwab Charles Corp (SCHW), ha riferito diverse vendite di azioni ordinarie della società il 01/10/2025. Il Form 4 mostra due vendite ai sensi del piano Rule 10b5-1 di 1.913 e 1.292 azioni (entrambi contrassegnati S(1)) e un'ulteriore disposizione di 25.153 azioni. La persona che riporta afferma che le vendite sono state effettuate nell'ambito di un piano di trading Rule 10b5-1 adottato il 15 novembre 2024. L'esecuzione è avvenuta in diverse operazioni a prezzi che vanno da $92.49 a $94.25, con i prezzi medi ponderati riportati come $93.0449 e $93.7434. Il Form 4 è stato firmato da un avvocato-in-fatto il 02/10/2025.
Paul V. Woolway, MD, Director de Banca de Schwab Charles Corp (SCHW), informó de múltiples ventas de acciones ordinarias de la empresa el 01/10/2025. El Formulario 4 muestra dos ventas bajo el plan Rule 10b5-1 de 1,913 y 1,292 acciones (ambos marcados S(1)) y una disposición adicional de 25,153 acciones. La persona reportante afirma que las ventas se realizaron bajo un plan de trading Rule 10b5-1 adoptado el 15 de noviembre de 2024. La ejecución ocurrió en varias operaciones a precios que van desde $92.49 hasta $94.25, con precios medios ponderados reportados como $93.0449 y $93.7434. El Formulario 4 fue firmado por un apoderado legal el 02/10/2025.
Paul V. Woolway, MD, Schwab Charles Corp (SCHW)의 최고 은행 책임자, 2025년 10월 1일 회사의 보통주 다건 매도를 보고했습니다. Form 4는 Rule 10b5-1 계획에 따른 두 차례 매도 1,913주와 1,292주(둘 다 S(1)로 표시) 및 25,153주의 추가 처분을 보여줍니다. 보고자에 의하면 매도는 2024년 11월 15일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌습니다. 실행은 $92.49에서 $94.25 사이의 여러 거래에서 발생했고, 가중 평균 가격은 각각 $93.0449와 $93.7434로 보고되었습니다. Form 4는 2025년 10월 2일에 대리인 변호사에 의해 서명되었습니다.
Paul V. Woolway, MD, Directeur de la Banque de Schwab Charles Corp (SCHW), a raporté plusieurs ventes d’actions ordinaires de la société le 01/10/2025. Le Form 4 montre deux ventes conformes au plan Rule 10b5-1 de 1 913 et 1 292 actions (toutes deux marquées S(1)) et une autre cession de 25 153 actions. La personne rapporteuse déclare que les ventes ont été réalisées dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 15 novembre 2024. L’exécution a eu lieu lors de plusieurs opérations à des prix allant de 92,49 à 94,25 $, les prix moyens pondérés étant respectivement 93,0449 $ et 93,7434 $. Le Form 4 a été signé par un mandataire le 02/10/2025.
Paul V. Woolway, MD, Chief Banking Officer von Schwab Charles Corp (SCHW), meldete am 01.10.2025 mehrere Verkäufe von Unternehmensaktien. Das Form 4 zeigt zwei Verkäufe gemäß dem Rule 10b5-1-Plan über 1.913 und 1.292 Aktien (beide mit S(1) gekennzeichnet) sowie eine weitere Veräußerung von 25.153 Aktien. Die meldende Person erklärt, dass die Verkäufe im Rahmen eines Rule 10b5-1-Handelsplans erfolgten, der am 15. November 2024 eingeführt wurde. Die Ausführung erfolgte in mehreren Transaktionen zu Preisen von 92,49 bis 94,25 USD, wobei die gewichteten Durchschnittspreise mit 93,0449 USD bzw. 93,7434 USD angegeben wurden. Das Form 4 wurde von einem Bevollmächtigten am 02.10.2025 unterschrieben.
بول ف. وولوي، الدكتور في الطب، كبير مسؤولي الخدمات المصرفية في Schwab Charles Corp (SCHW)، أبلغ عن عدة مبيعات لأسهم الشركة العادية في تاريخ 01/10/2025. يظهر النموذج 4 بيعين بموجب خطة Rule 10b5-1 لعدد 1,913 و1,292 سهماً (كلاهما مُميزان بـ S(1)) وتصفية أخرى لـ 25,153 سهماً. يذكر الشخص المبلّغ أن المبيعات تمت بموجب خطة تداول Rule 10b5-1 التي اعتمدت في 15 نوفمبر 2024. تمت التنفيذ في عدة صفقات بأسعار تتراوح بين $92.49 و$94.25، مع أسعار متوسطة مرجحة مذكورة كـ $93.0449 و$93.7434. قام المحامي الوكيل بتوقيع النموذج 4 في 02/10/2025.
保罗·V·伍尔维,医学博士,Schwab Charles Corp (SCHW)的首席银行官,在 2025/10/01 报告了该公司普通股的多笔出售。Form 4 显示两笔按 Rule 10b5-1 计划进行的出售,分别为 1,913 股和 1,292 股(均标记为 S(1)),以及另一次处置 25,153 股。报告人表示这些出售是在于 2024 年 11 月 15 日 通过的 Rule 10b5-1 交易计划之下进行的。交易在多笔交易中完成,价格区间为 $92.49 至 $94.25,加权平均价格分别报告为 $93.0449 和 $93.7434。Form 4 由代理律师在 2025/10/02 签署。
- Sales were executed under a Rule 10b5-1 plan adopted on November 15, 2024
- Form 4 discloses weighted average prices and price ranges ($92.49–$94.25) and offers to provide full trade details upon request
- Form 4 was signed by an attorney-in-fact on 10/02/2025, indicating timely filing following the trades
- Reporting person disposed of 25,153 shares (plus separate sales of 1,913 and 1,292 shares) which reduces insider holdings
- Some ownership lines and totals in the table are ambiguous, requiring supplemental detail for precise post-transaction holdings
Insights
Insider sold shares under a pre-established 10b5-1 plan on 10/01/2025.
The filing documents sales of 1,913 and 1,292 shares executed in multiple trades and a listed disposal of 25,153 shares. The reporting person disclosed the plan adoption date as November 15, 2024, and provided weighted average sale prices of $93.0449 and $93.7434.
This matters because the filing shows the trades were pre-authorized under a Rule 10b5-1 plan, and the execution prices span $92.49–$94.25, details that are relevant to transaction timing and proceeds but do not, by themselves, disclose intent.
Filing confirms required disclosure and use of attorney-in-fact signature on 10/02/2025.
The Form 4 identifies the reporting person as an officer (MD, Chief Banking Officer) and includes an attorney-in-fact signature (P. Blake Allen), indicating the filing was executed promptly after the trades. The explanatory notes include price ranges and a willingness to provide full trade details on request.
That transparency fulfills Section 16 reporting mechanics; the filing contains explicit trade counts and price ranges but does not disclose proceeds or purpose of sales.
Paul V. Woolway, MD, Chief Banking Officer di Schwab Charles Corp (SCHW), ha riferito diverse vendite di azioni ordinarie della società il 01/10/2025. Il Form 4 mostra due vendite ai sensi del piano Rule 10b5-1 di 1.913 e 1.292 azioni (entrambi contrassegnati S(1)) e un'ulteriore disposizione di 25.153 azioni. La persona che riporta afferma che le vendite sono state effettuate nell'ambito di un piano di trading Rule 10b5-1 adottato il 15 novembre 2024. L'esecuzione è avvenuta in diverse operazioni a prezzi che vanno da $92.49 a $94.25, con i prezzi medi ponderati riportati come $93.0449 e $93.7434. Il Form 4 è stato firmato da un avvocato-in-fatto il 02/10/2025.
Paul V. Woolway, MD, Director de Banca de Schwab Charles Corp (SCHW), informó de múltiples ventas de acciones ordinarias de la empresa el 01/10/2025. El Formulario 4 muestra dos ventas bajo el plan Rule 10b5-1 de 1,913 y 1,292 acciones (ambos marcados S(1)) y una disposición adicional de 25,153 acciones. La persona reportante afirma que las ventas se realizaron bajo un plan de trading Rule 10b5-1 adoptado el 15 de noviembre de 2024. La ejecución ocurrió en varias operaciones a precios que van desde $92.49 hasta $94.25, con precios medios ponderados reportados como $93.0449 y $93.7434. El Formulario 4 fue firmado por un apoderado legal el 02/10/2025.
Paul V. Woolway, MD, Schwab Charles Corp (SCHW)의 최고 은행 책임자, 2025년 10월 1일 회사의 보통주 다건 매도를 보고했습니다. Form 4는 Rule 10b5-1 계획에 따른 두 차례 매도 1,913주와 1,292주(둘 다 S(1)로 표시) 및 25,153주의 추가 처분을 보여줍니다. 보고자에 의하면 매도는 2024년 11월 15일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌습니다. 실행은 $92.49에서 $94.25 사이의 여러 거래에서 발생했고, 가중 평균 가격은 각각 $93.0449와 $93.7434로 보고되었습니다. Form 4는 2025년 10월 2일에 대리인 변호사에 의해 서명되었습니다.
Paul V. Woolway, MD, Directeur de la Banque de Schwab Charles Corp (SCHW), a raporté plusieurs ventes d’actions ordinaires de la société le 01/10/2025. Le Form 4 montre deux ventes conformes au plan Rule 10b5-1 de 1 913 et 1 292 actions (toutes deux marquées S(1)) et une autre cession de 25 153 actions. La personne rapporteuse déclare que les ventes ont été réalisées dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 15 novembre 2024. L’exécution a eu lieu lors de plusieurs opérations à des prix allant de 92,49 à 94,25 $, les prix moyens pondérés étant respectivement 93,0449 $ et 93,7434 $. Le Form 4 a été signé par un mandataire le 02/10/2025.
Paul V. Woolway, MD, Chief Banking Officer von Schwab Charles Corp (SCHW), meldete am 01.10.2025 mehrere Verkäufe von Unternehmensaktien. Das Form 4 zeigt zwei Verkäufe gemäß dem Rule 10b5-1-Plan über 1.913 und 1.292 Aktien (beide mit S(1) gekennzeichnet) sowie eine weitere Veräußerung von 25.153 Aktien. Die meldende Person erklärt, dass die Verkäufe im Rahmen eines Rule 10b5-1-Handelsplans erfolgten, der am 15. November 2024 eingeführt wurde. Die Ausführung erfolgte in mehreren Transaktionen zu Preisen von 92,49 bis 94,25 USD, wobei die gewichteten Durchschnittspreise mit 93,0449 USD bzw. 93,7434 USD angegeben wurden. Das Form 4 wurde von einem Bevollmächtigten am 02.10.2025 unterschrieben.